Search by Drug Name or NDC

    NDC 58552-0337-01 PHENAGIL 3.5; 29; 10 mg/1; mg/1; mg/1 Details

    PHENAGIL 3.5; 29; 10 mg/1; mg/1; mg/1

    PHENAGIL is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Gil Pharmaceutical Corp.. The primary component is CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 58552-0337
    Product ID 58552-337_0875cad9-99b4-4d4f-e063-6394a90a3bbc
    Associated GPIs
    GCN Sequence Number 085438
    GCN Sequence Number Description chlorpheniramine/phenyleph/DM TABLET 3.5-10-29 ORAL
    HIC3 B3R
    HIC3 Description NON-OPIOID ANTITUS-1ST GEN.ANTIHISTAMINE-DECONGEST
    GCN 54919
    HICL Sequence Number 000375
    HICL Sequence Number Description CHLORPHENIRAMINE MALEATE/PHENYLEPHRINE HCL/DEXTROMETHORPHAN
    Brand/Generic Brand
    Proprietary Name PHENAGIL
    Proprietary Name Suffix n/a
    Non-Proprietary Name Chlorpheniramine maleate, Dextromethorphan HBr and Phenylephrine HCL
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 3.5; 29; 10
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Gil Pharmaceutical Corp.
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Rece
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2024-12-31

    Package

    NDC 58552-0337-01 (58552033701)

    NDC Package Code 58552-337-01
    Billing NDC 58552033701
    Package 100 TABLET in 1 BOTTLE (58552-337-01)
    Marketing Start Date 2022-05-26
    NDC Exclude Flag N
    Pricing Information N/A